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Ankaferd Blood Stopper with antibiofilm potential successfully inhibits the extracellular
matrix degradation enzymes and promotes wound healing of 3T3 fibroblasts in vitro
1

2,

3

4

Rukiye BORAN , Tuba BAYGAR *, Nurdan SARAÇ , Aysel UĞUR
Medical Laboratory Program, Department of Medical Services and Techniques, Vocational School of Health Services,
Aksaray University, Aksaray, Turkey
2
Material Research Laboratory, Research Laboratories Center, Muğla Sıtkı Koçman University, Muğla, Turkey
3
Department of Biology, Faculty of Science, Muğla Sıtkı Koçman University, Muğla, Turkey
4
Section of Medical Microbiology, Department of Basic Sciences, Faculty of Dentistry, Gazi University, Ankara, Turkey
1

Received: 13.12.2017

Accepted/Published Online: 07.04.2018

Final Version: 14.06.2018

Background/aim: The potential inhibitory effects of Ankaferd Blood Stopper (ABS) against biofilm formation of oral microorganisms
and its capacity for collagenase, hyaluronidase, and elastase inhibitions that have important roles in wound healing have been investigated.
Materials and methods: The wound healing potential was determined by its inhibition ability on collagenase, hyaluronidase, and
elastase enzyme activities and was evaluated via scratch wound healing assay on murine 3T3 fibroblasts. The antibiofilm activity was
tested against eight oral microorganisms using the crystal violet staining method.
Results: At 10% ABS successfully inhibited the biofilm formation of the tested microorganisms. Enzyme inhibition analysis revealed
that 3% ABS significantly inhibited all three enzymes related to wound healing. The scratch assay showed that wound closure was faster
than that of the control for the 3% ABS/plate.
Conclusion: The findings of the present study indicated that ABS has effective wound healing potential with its strong antibiofilm
activity against oral cavity microorganisms.
Key words: Ankaferd Blood Stopper, enzyme inhibition, antibiofilm, wound healing

1. Introduction
Ankaferd Blood Stopper (ABS) is an herbal agent
composed of Thymus vulgaris, Urtica dioica, Alpinia
officinarum, Glycyrrhiza glabra, and Vitis vinifera (1),
and it contains no inorganic or synthetic additives (2).
Each of the plants used in ABS has some effects on blood
cells, endothelium, cell proliferation, vascular dynamics,
angiogenesis, apoptosis, inflammation, or cell mediators
(3,4). This product has been licensed for use for external,
dental, and postsurgical major or minor hemorrhages (5).
The basic mechanism of action for ABS is the formation
of an encapsulated protein network, representing focal
points for vital erythrocyte aggregation (6).
ABS can be used against bleeding, such as in
adenoidectomy/tonsillectomy, gastrointestinal hemorrhages,
anterior epistaxis, and urological surgery (5–9). Dental use
of ABS has also been reported (10–12). In addition, several
scientific papers have been published representing the
potential use of ABS as an anticancer (13), antiangiogenesis
* Correspondence: tubaygar@mu.edu.tr

(14), antifungal (15), antimicrobial (16,17), antioxidant,
antimutagenic (18), and wound healing agent (19–21).
Wound healing is a highly complex biological
process, which requires the coordinated behavior of
some factors such as blood cells, connective tissue
and epithelial cells, inflammatory cells, molecular and
humoral components, and many soluble factors (22).
Among the important factors involved in the control of
the wound healing process are the extracellular matrix
(ECM) macromolecules including collagens, elastins,
glycosaminoglycans, glycoproteins, proteoglycans, and
polysaccharides (23).
Collagen plays an essential role in all phases of
the wound healing process, including hemostasis,
inflammation, proliferation, and remodeling. Collagen
creates an appropriate healing environment by facilitating
wound healing with the organization and accumulation of
newly formed fibers and granulation tissue in the wound
bed (24). Deficiency in specific collagens is closely linked to
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abnormal wound closure, so collagen-based formulations
have played roles in providing wound healing (25), dural
closure, reinforcement of compromised tissue, and guided
tissue regeneration (24). Elastin is an insoluble ECM protein
that provides flexibility and elasticity to skin arteries and
lungs. Because of its highly cross-linked nature, elastin is
not soluble and is difficult to process into new biomaterials
(26). Glycosaminoglycan chains are very important
players in the wound healing process. The most important
is hyaluronic acid, which is present in large quantities in
the skin and provides viscoelasticity and hydrophilicity
of the tissue. Hyaluronic acid interacts with cell surface
receptors. Interaction of hyaluronic acid with its receptor
causes considerable events in the wound repair process,
such as collagen secretion, modulation of inflammation,
cell migration, chemotaxis, and angiogenesis (27,28).
However, the inflammatory response accelerates the
synthesis of dermal enzymes, (matrix metalloproteinase,
elastase, hyaluronidase, etc.), leading to the degradation
of ECM. Collagenase can break down molecules such
as collagen, elastin, fibronectin, aggrecan, gelatin, and
laminin (29). Elastase has a broad substrate portfolio,
such as elastin, fibronectin, collagen, and other ECM
proteins (30). Hyaluronidases play an important role
in the degradation of cellular hyaluronan. The scratch
wound healing assay is used for testing the effects of crude
extracts of medicinal plants, isolated compounds, and
pharmaceutical preparations on fibroblast migration and
proliferation into artificially wounded monolayers (31).
Shortly after an injury, microbial colonization begins
to occur in the wound, and at about the same time,
there is confusion between the innate immune response,
pathogens, and microflora. However, microorganisms
can cause infection, which can impair the wound healing
process and result in chronic wounds (32). The human
oral cavity includes different living areas such as the
teeth, gums, cheeks, tongue, palate, and tonsils, which
are colonized by bacteria. The oral cavity is a propitious
environment for bacteria with different tissue tropisms to
colonize and grow due to its diverse surfaces. Reports have
shown that almost 800 species of microorganisms inhabit
this environment and a number of these are associated with
oral diseases (33). Microorganisms from the oral cavity
have been shown to cause oral infectious diseases such as
periodontitis, caries, endodontic infections, tonsillitis, and
alveolar osteitis. Various evidence emerged that links oral
bacteria to some systemic diseases, including pneumonia,
cardiovascular disease, preterm birth, stroke, and
diabetes (34). The use of antimicrobial agents to prevent
contamination of oral wounds is highly needed for healing,
particularly during periodontal and oral and maxillofacial
surgery, specifically in the scope of implantodontics. In
various cases in dentistry, infections of oral wounds can be
stopped with different antimicrobials and antiseptics (35).
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The presence of microbial infection may prevent the
wound healing process (36). Microbial colonization may
occur in all chronic or acute injuries (37) and the effects on
the healing process of microbial wound colonization are
of great importance because infection destroys the wound
repair process, slowing epithelization (38) and delaying
healing (39). Deterioration in the wound healing process
causes morbidity and mortality and significant economic
and social impacts in a large proportion of the population
(40). Therefore, a higher level of interest and research is
needed to assess new therapeutic agents that can speed
wound healing and reduce the incidence of infected
wounds (41).
Therefore, in this study, the wound healing effect of
ABS was determined by assessing its potential inhibitory
activity on collagenase, elastase, and hyaluronidase
enzymes, all of which have essential roles in the wound
healing process. Thereafter, the wound healing properties
of ABS were screened on 3T3 murine fibroblasts with an in
vitro scratch assay and its antibiofilm activity was analyzed
against oral cavity microorganisms.
2. Materials and methods
ABS is a patented product (Turkish Patent No. 2007-0114485) comprising a standardized mixture of the plants
G. glabra (90 µg/mL), V. vinifera (80 µg/mL), U. dioica
(60 µg/mL), T. vulgaris (50 µg/mL), and A. officinarum
(70 µg/mL). A 2-mL vial of ABS was obtained from the
manufacturer (Trend Teknoloji İlaç AŞ, Ankara, Turkey).
Throughout the study, a 10% (v/v) final concentration of
ABS was tested for antibiofilm activity; 3% and 0.3% (v/v)
ABS were tested for enzyme inhibition assay and 3% (v/v)
ABS was tested for in vitro scratch assay.
2.1. Microorganisms and culture conditions
Candida albicans (ATCC 10239), Staphylococcus aureus
(ATCC 25923), and Streptococcus mutans (ATCC
25175) were purchased from the American Type Culture
Collection (ATCC). Streptococcus mitis (DSMZ 12643),
Streptococcus oralis (DSMZ 20395), Streptococcus sobrinus
(DSMZ 20742), Streptococcus sanguinis (DSMZ 20068), and
Streptococcus parasanguinis (DSMZ 6778) were purchased
from the German Collections of Microorganisms and
Cell Cultures (DSMZ). S. aureus was cultured in nutrient
broth at 37 °C. S. mutans, S. sanguinis, S. mitis, S. oralis, S.
sobrinus, and S. parasanguinis were cultured in brain heart
infusion broth in a humidified atmosphere of 5% CO2 at 37
°C. C. albicans was cultured in Sabouraud dextrose broth
at 30 °C.
2.2. Antibiofilm activity
Antibiofilm activities of ABS were determined against
the abovementioned strains using crystal violet staining.
Inocula containing 5 × 105 cfu/mL cells and fresh broth
medium containing 5% sucrose and 10% ABS (final
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concentration in each tube) were inoculated into tubes
and were incubated under appropriate conditions for each
microorganism for 72 h. After the incubation period, tubes
were rinsed 3 times with phosphate buffer solution (PBS)
to remove planktonic cells and fixed by drying at 37 °C for
2 h. Dried tubes were stained with 0.1% (w/v) crystal violet
for 10 min and were rewashed with water before being left
to dry. The bound dye was extracted from the adherent
cells using 33% acetic acid and the optical densities of the
solutions were measured at 550 nm (Multiskan GO UV/Vis
Microplate Spectrophotometer, Thermo Fisher Scientific,
USA). The experiments were performed in duplicate.
2.3. Scanning electron microscopy (SEM)
Biofilm inhibition of the ABS was also observed by SEM
using glass coverslips (42). Sterile circle glass coverslips
(20 × 20 mm) were placed in biofilm assay tubes, which
were prepared as described above. After appropriate
incubation periods for each microorganism, the coverslips
were gently rinsed with PBS (pH 7.4) and fixed with
2.5% glutaraldehyde at 4 °C for 2 h. After glutaraldehyde
fixation, the coverslips were washed again with PBS for 1
h and dehydrated by increasing concentrations of ethanol.
Specimens were air-dried and coated by gold (Emmitech
K550, UK) before examination by SEM (JSM-7600F, JEOL
Ltd., Tokyo, Japan).
2.4. Collagenase inhibitory activity
Collagenase (EC 3.4.24.3) (0.8 U/mL) was mixed with the
same volume of tricine buffer (pH 7.5) (prepared with 400
mM NaCl and 10 mM CaCl2) and ABS (0.3% and 3%). The
mixture was incubated at 37 °C for 20 min before 50 µL of
N-(3-[2-furyl]-acryloyl)-Leu-Gly-Pro-Ala (1.6 mM) was
added. Epigallocatechin gallate (EGCG) and deionized
water were used as the reference and negative control,
respectively. To measure the collagenase inhibitory activity
of ABS, absorbances were determined at 335 nm quickly
and at 2-min intervals for 20 min (43).
2.5. Hyaluronidase inhibitory activity
One hundred microliters of ABS (0.3% and 3%) and 50
µL of bovine hyaluronidase (7900 U/mL) were stirred
and incubated at 37 °C for 20 min. Then 100 µL of CaCl2
(12.5 mM) was added and again incubated under the
same conditions. After incubation, 250 µL of sodium
hyaluronate (1.2 mg/mL) was added and incubated at 37
°C for 40 min. The solution was blended with 100 µL of 0.2
M sodium borate and 50 µL of 0.2 M NaOH and incubated
in a bath of boiled water for 3 min. After cooling to room
temperature, a p-dimethylaminobenzaldehyde solution
was added to the mixture and incubated under the same
conditions (44). Tannic acid and deionized water were
used as the reference and negative control, respectively.
To measure the hyaluronidase inhibitory activity of ABS,
absorbances were determined at 585 nm.

2.6. Elastase inhibitory activity
Fifty microliters of Tris-HCl buffer (200 mM, pH 8.0),
25 µL of elastase (EC 3.4.21.36), and 50 µL of ABS
(0.3% and 3%) were stirred and incubated at 25 °C for
20 min. Then 125 µL of N-succinyl-Ala-Ala-Ala-pnitroanilide solution was added and incubated under
same conditions. EGCG and deionized water were used
as the reference and negative control, respectively. The
absorbance was monitored at 410 nm for 20 min (44).
For enzyme inhibition analysis, the following formula
was used to determine the percentage of inhibition of
collagenase, hyaluronidase, and elastase enzymes:
Inhibition (%) = [(A – B) – (T – D)] / (A – B) × 100
Here, A is the absorbance without the test sample, B
is the absorbance without the test sample and enzyme,
T is the absorbance with the test sample, and D is the
absorbance with the test sample without the enzyme.
2.7. Determination of in vitro scratch wound healing
assay
2.7.1. Cell culture
The mouse embryonic fibroblast cell line NIH 3T3
(3T3), obtained from the ATCC (Manassas, VA, USA),
was grown in Dulbecco’s minimal essential medium
supplemented with 10% heat-inactivated fetal calf
serum, L-glutamine (2 mM), penicillin (100 IU/mL),
and streptomycin (100 µg/mL). Cells were maintained
at 37 °C in a humidified atmosphere of 5% CO2 and
subcultured after being detached from culture flasks with
0.05% trypsin and 0.002% EDTA solution. Exponentially
growing cells were seeded onto a cell culture dish (60 × 10
mm) at a density of 75 × 104/cm2 and were maintained in
culture for 24 h prior to treatments.
2.7.2. Scratch wound healing assay
The spreading and migration capabilities of 3T3
fibroblasts were assessed using a scratch wound assay,
which measures the expansion of a cell population on
surfaces (45). Before deciding the amount of the ABS, a
pilot study was employed at different concentrations of
ABS and 3% ABS/plate was found to be the most effective
concentration to exhibit the wound healing property.
Briefly, a linear wound was generated in the monolayer
with a sterile 100-µL plastic pipette tip. Any cellular
debris was removed by washing the plate with Dulbecco’s
phosphate-buffered saline. Thereafter, cells were treated
with 3% ABS/plate and maintained in culture for a period
of 48 h. Controls consisted of cells cultured in basal
medium (untreated controls). Representative images
from each cell culture dish of the scratched areas were
photographed using a Leica DM IL microscope (Leica
Microsystems, Wetzlar, Germany) to estimate the relative
migration of cells. The experiments were performed in
duplicate.
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3. Result
The Table shows the inhibition of collagenase,
hyaluronidase, and elastase of ABS. In vitro collagenase,
hyaluronidase, and elastase inhibitory activity assay results
showed that ABS displayed a significant inhibitory activity
on all three enzymes at 10 µg/mL concentrations. The
inhibition values of ABS on collagenase, hyaluronidase,
and elastase were 88 ± 0.31%, 96.8 ± 0.47%, and 66
± 0.07%, respectively (Table). ABS exhibited enzyme
inhibitory activity in a dose-dependent manner. ABS
showed 10.5 ± 0.1% collagenase inhibitory activity, 45 ±
0.3% hyaluronidase inhibitory activity, and 12 ± 0.01%
elastase inhibitory activity at the dose of 0.3%. In addition,
ABS showed very strong enzyme inhibitory activity at 3%
as compared to standard epigallocatechin gallate (36 ±
0.31% inhibition for collagenase and 47 ± 0.7% inhibition
for elastase at 100 µg/mL) and tannic acid (61.6 ± 0.81%
inhibition for hyaluronidase at 1 mg/mL concentration).
For in vitro determination of biofilm formation, crystal
violet is commonly used and its density is measured
spectrophotometrically. Crystal violet dye not only displays
stains but also displays a small quantity of molecules that
change the formation of biofilm. ABS inhibited the growth
of the biofilm layer of S. aureus, S. sanguinis, S. mitis, S.
sobrinus, and S. parasanguinis by 94.48 ± 0.96%, 87.00 ±
0.92%, 86.57 ± 0.97%, 82.38 ± 0.88%, and 80.17 ± 1.12%,
respectively. However, ABS at the same concentration
inhibited S. oralis, C. albicans, and S. mutans biofilm
growth by 62.13 ± 0.04%, 38.80 ± 0.57%, and 7.89 ± 0.57%,
respectively (Figure 1).
The highest antibiofilm activity of ABS of 94.48 ±
0.96% was also monitored by SEM against S. aureus
biofilm formation (Figure 2). After ABS treatment,
planktonic S. aureus cells were observable, but there was
no biofilm formation on the coverslips. Similar to all other
microorganisms, the control group of S. aureus without
ABS exhibited typical biofilm structure (Figure 2).

To investigate the effect of ABS on fibroblast migration
and proliferation, the scratch wound healing assay was
applied to 3T3 fibroblasts and images were taken at regular
intervals. After administration of 1 µL of ABS to cell culture
plates, fibroblasts were stimulated for cell migration. After
48 h, the scar had completely healed on both control group
and ABS-treated plates (Figure 3).
4. Discussion
ABS is a medicinal plant extract that is produced by a
registered Turkish company. ABS has been used as a local
hemostatic agent in surgery, but it was also shown to
promote healing. There are some studies that have been
performed to investigate the efficacy of ABS on soft-tissue
healing in animal models.
Akbal et al. (19) showed that oral ABS application
prevented inflammation, scar formation, weight loss,
and mortality in caustic esophageal injury in the study of
mucosal wound healing in a rat model. In another study
based on a rat skin defect model, Akalin et al. (20) reported
higher collagen deposition and fibroblast proliferation
scores and lower inflammatory scores in the ABS group.
Similarly, according to Yüce et al. (21), collagen deposits of
the tissues increased until day 10 in an experimental skin
incision model. However, Aydın et al. (46) did not obtain
positive results after histological administration to mice in
tendon healing.
In wound healing, there are three consecutive steps of
inflammation, tissue formation, and tissue remodeling, and
it is a complex process involving cells, intermediates, and
ECM components. Traditional wound healing treatments
are expected to contribute to the wound healing process by
influencing one or more of these stages (47). Therefore, in
this study, the inhibition of enzymes that break down the
ECM molecules of ABS was investigated. It is now recognized
that the ECM is not only an architectural support for tissues
but also plays an important role in cell regulation. It is now

Table. Anticollagenase, antihyaluronidase, and antielastase activities of the ABS.
Inhibition % ± SEMa

a

Material

Concentration

Collagenase

Hyaluronidase

Elastase

ABS

3%
0.3%

88 ± 0.31
10.5 ± 0.1

96.8 ± 0.47
45 ± 0.3

66 ± 0.07
12 ± 0.01

Epigallocatechin gallate (reference)

100 µg/mL

36 ± 0.31

NTc

47 ± 0.7

Tannic acid (reference)

1 mg/mL
100 µg/mL

NTc
NTc

61.6 ± 0.81
–b

NTc
NTc

Standard error of the mean, b no activity, c not tested.
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Antibiofilm activity of ABS

% inhibition

120.00
94.48

100.00
60.00
40.00
20.00

82.38 87.00 80.17

86.57

80.00

62.13
38.80
7.89

0.00

Figure 1. Antibiofilm activity of the ABS against oral cavity
microorganisms. Error bars represent standard deviations.

clear that significant ECM changes during wound healing
have made it a very important player in this process (23).
Effects of the individual plant extracts found in ABS
on enzyme inhibitions are reported. Extracts of T. vulgaris
showed collagenase and elastase inhibition of almost 25%
and 17%, respectively, while the hyaluronidase inhibition
rate was 100% (48). In another study, ursolic acid extracted
from U. dioica exhibited elastase and collagenase inhibition
activity of 24.51% and 16.23%, respectively (49).
Similarly, Carini et al. (50) reported that procyanidins
from V. vinifera seeds inhibited elastase enzyme (IC50 =
5.4 µM). In another study, A. officinarum rhizome extract
showed very low elastase inhibition at 100 µg/mL (1%) and
1000 µg/mL (8%) concentrations (44). The results of the
present study show that ABS has higher enzyme inhibition
activity than the plants used in its formulation. This is
probably due to the synergistic activity of the extracts found
in ABS. The cytotoxic activity of ABS was also evaluated
for cancer cell lines. Turk et al. (51) determined the effect
of ABS on the viability of melanoma cells; cells treated with
ABS showed a significant decrease in cell viability compared
to control groups.
Antimicrobial resistance levels within a biofilm can reach
1000-fold higher than in planktonic cells. An estimated
65%–80% of all infections are thought to be biofilm-related;
therefore, this increase in antibiotic resistance presents a
serious challenge (33). The wound healing process can also
affect the microbial flora. It has been found that the total
absence of microflora affects the wound healing process
positively. However, colonization occurs immediately after
injury and microbial colonization is inevitable in clinical
practice. When there is injury, initially, the host’s immune
system controls microbial proliferation but gradually
develops microorganisms of the wound area, developing
biofilms and resistance to host immunity (32,52). In
previous works, the antimicrobial activity of ABS was tested
against clinical isolates (16,53), but, as far as we know, there
is no study in the literature that examines the effects of ABS

Figure 2. Scanning electron micrographs of ABS against biofilm
development of S. aureus: A) the untreated group, B) ABS-treated
group. Scale bars are shown within the figures.

on biofilm development. The results of the present study
showed that ABS can effectively inhibit biofilm formation of
oral microorganisms.
There are a few studies about the in vivo wound healing
potential of ABS. İşler et al. (54) observed that the application
of ABS decreased the occurrence of inflammation and
necrosis while increasing new bone formation in the early
bone healing period for rats. Akalin et al. (20) investigated
the efficacy of ABS on the healing of dermal wounds in a
rat model and concluded that the ABS-treated group was
superior to the control group in terms of inflammatory
scoring, type I/type III collagen ratio, and wound contraction
rates. Kaya et al. (55) investigated the effects of ABS on burn
healing using a rat burn model and wound diameter and
inflammation were found to be significantly decreased
while fibrosis was significantly increased in the ABS group
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0. hour

18. hour

24. hour

48. hour
Figure 3. Images of scratch wound healing assay for 0, 18, 24, and 48 h
after creating the scratch. Images on the left side represent the control
group.

on the 14th day. To our knowledge, this is the first study on
the in vitro wound healing potential of ABS.
ABS has been used as a hemostatic agent for different
types of bleeding. In this study, the antibiofilm activity of
ABS against oral streptococci has been revealed with in vitro
analysis and also visualized by SEM. ECM components are
required at each stage of wound healing and it is known
that recovery does not continue without these ECM
components. In this study, the collagenase, hyaluronidase,
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and elastase enzyme inhibitory activities of ABS were
investigated for the first time. In vitro experiments have
shown that ABS can enhance the wound healing process by
providing inhibition of ECM-degrading enzymes during
wound repair. Our findings also demonstrated that ABS
enhanced the stimulated migration of 3T3 fibroblasts to
an artificial wounded area. Besides its hemostatic activity,
ABS can be used effectively as an antibiofilm and wound
healing agent for oral cavity wounds.
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